Sphere Fluidics’ Blogs

Dr Elvira discusses disruptive technologies, ranging from 3D-printed assembled capillary devices to blood-brain barrier-on-a-chip models.

2020 marked the tenth anniversary of Sphere Fluidics. Read about some key achievements on our journey to date

Dr. Xin Li explores how picodroplet technology can overcome the current synthetic biology workflow challenges.

Professor Chris Abell talks about developing Cyto-Mine®, and novel applications of droplet-based microfluidic technology

Professor Matthew Dalby explores accelerating and improving therapeutic discovery and regenerative medicine by inspiring the next generation of talent.

Professor Wilhelm Huck discusses the application of single cell analysis in diagnostics and using droplet microfluidics to isolate circulating tumor cells.

Our CEO, Dr Frank Craig, discusses how Cyto-Mine® reduces the cell line development process by 3 months, enabling researchers to make a new vaccine much faster

Dr Fay Saunders shares her experience of using Cyto-Mine® in cell line development and recombinant protein expression at FUJIFILM Diosynth Biotechnologies.

Dr Jon Dempsey, Pathway Biopharma, explores how companies can improve product quality and yields, as well as shorten overall cell line development timelines.

Dr Tristan Vaughan shares his perspectives on biological medicines development and the potential of single cell analysis platforms.

Learn more about the benefits of switching to picodroplet-based technologies for antibody discovery.

Learn how the use of picodroplets increases the speed and efficiency of selective cell screening and reduces screening costs.

This article outlines some techniques and tips on optimizing PMT settings for sorting and dispensing using Cyto-Mine®.